PhoenixBio Co., Ltd.
Tokyo Stock Exchange 6190.T
PhoenixBio Co., Ltd. Market Capitalization on January 14, 2025: USD 8.43 M
PhoenixBio Co., Ltd. Market Capitalization is USD 8.43 M on January 14, 2025, a -42.42% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
-
PhoenixBio Co., Ltd. 52-week high Market Capitalization is USD 14.64 M on July 29, 2024, which is 73.68% above the current Market Capitalization.
-
PhoenixBio Co., Ltd. 52-week low Market Capitalization is USD 7.93 M on January 07, 2025, which is -5.91% below the current Market Capitalization.
-
PhoenixBio Co., Ltd. average Market Capitalization for the last 52 weeks is USD 11.44 M.
Key data
| Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
|---|
Market news
Loading...
Tokyo Stock Exchange: 6190.T
| CEO | Takashi Shimada |
| IPO Date | March 18, 2016 |
| Location | Japan |
| Headquarters | 3-4-1 Kagamiyama |
| Employees | 70 |
| Sector | Health Care |
| Industries | |
Description
PhoenixBio Co., Ltd. provides contract study services for drug discovery and development primarily in Japan. The company uses PXB-mouse, a chimeric mouse with a humanized liver for use in drug development experiments; and in vitro studies using fresh human hepatocytes taken from PXB-cells. The chimeric mouse model with a humanized liver is used for in vivo studies in gene therapeutics, NASH/NAFLD drug development programs, anti-viral therapeutic tests, DMPK/toxicity studies, and custom transplantations. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email